GSK3B and urinary bladder cancer: Studies have reported that microRNA-135a can activate the Wnt/β-catenin signaling pathway by downregulating glycogen synthase kinase 3β (GSK-3β), thereby accelerating the EMT and migration of bladder cancer cells [64].